Cargando…

Von Hippel-Lindau status influences phenotype of liver cancers arising from PTEN loss

BACKGROUND: PTEN loss contributes to the development of liver diseases including hepatic steatosis and both hepatocellular carcinoma (HCC) and cholangiocarcinoma (CC). The factors that influence the penetrance of these conditions are unclear. We explored the influence of sustained hypoxia signaling...

Descripción completa

Detalles Bibliográficos
Autores principales: Sendor, Adam B, Hacker, Kathryn E, Chen, Shufen, Corona, Armando L, Sen, Oishee, Chiang, Derek Y, Snavely, Anna, Rogers, Arlin B, Montgomery, Stephanie A, Rathmell, W Kimryn, McRee, Autumn J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4383253/
https://www.ncbi.nlm.nih.gov/pubmed/25844041
http://dx.doi.org/10.2147/GICTT.S72274
_version_ 1782364702789074944
author Sendor, Adam B
Hacker, Kathryn E
Chen, Shufen
Corona, Armando L
Sen, Oishee
Chiang, Derek Y
Snavely, Anna
Rogers, Arlin B
Montgomery, Stephanie A
Rathmell, W Kimryn
McRee, Autumn J
author_facet Sendor, Adam B
Hacker, Kathryn E
Chen, Shufen
Corona, Armando L
Sen, Oishee
Chiang, Derek Y
Snavely, Anna
Rogers, Arlin B
Montgomery, Stephanie A
Rathmell, W Kimryn
McRee, Autumn J
author_sort Sendor, Adam B
collection PubMed
description BACKGROUND: PTEN loss contributes to the development of liver diseases including hepatic steatosis and both hepatocellular carcinoma (HCC) and cholangiocarcinoma (CC). The factors that influence the penetrance of these conditions are unclear. We explored the influence of sustained hypoxia signaling through co-deletion of Pten and Vhl in a murine model. METHODS: We used a CreER-linked Keratin 18 mouse model to conditionally delete Pten, Vhl or both in somatic cells of adult mice, evaluating the resultant tumors by histology and gene expression microarray. Existing sets of gene expression data for human HCC and CC were examined for pathways related to those observed in the murine tumors, and a cohort of human CC samples was evaluated for relationships between HIF-1α expression and clinical outcomes. RESULTS: Both Pten deletion genotypes developed liver tumors, but with differing phenotypes. Pten deletion alone led to large hepatic tumors with widespread hepatosteatosis. Co-deletion of Pten and Vhl with the Keratin 18 promoter resulted in reduced steatosis and a reduced tumor burden that was characterized by a trabecular architecture similar to CC. Genes associated with hepatic steatosis were coordinately expressed in the human HCC dataset, while genes involved in hypoxia response were upregulated in tumors from the human CC dataset. HIF-1α expression and overall survival were examined in an independent cohort of human CC tumors with no statistical differences uncovered. CONCLUSION: Pten deletion in Keratin 18 expressing cells leads to aggressive tumor formation and widespread steatosis in mouse livers. Co-deletion of Vhl and Pten results in lower tumor burden with gene expression profiling suggesting a switch from a profile of lipid deposition to an expression profile more consistent with upregulation of the hypoxia response pathway. A relationship between tumor hypoxia signaling and altered hepatic steatotic response suggests that competing influences may alter tumor phenotypes.
format Online
Article
Text
id pubmed-4383253
institution National Center for Biotechnology Information
language English
publishDate 2015
record_format MEDLINE/PubMed
spelling pubmed-43832532015-04-02 Von Hippel-Lindau status influences phenotype of liver cancers arising from PTEN loss Sendor, Adam B Hacker, Kathryn E Chen, Shufen Corona, Armando L Sen, Oishee Chiang, Derek Y Snavely, Anna Rogers, Arlin B Montgomery, Stephanie A Rathmell, W Kimryn McRee, Autumn J Gastrointest Cancer Article BACKGROUND: PTEN loss contributes to the development of liver diseases including hepatic steatosis and both hepatocellular carcinoma (HCC) and cholangiocarcinoma (CC). The factors that influence the penetrance of these conditions are unclear. We explored the influence of sustained hypoxia signaling through co-deletion of Pten and Vhl in a murine model. METHODS: We used a CreER-linked Keratin 18 mouse model to conditionally delete Pten, Vhl or both in somatic cells of adult mice, evaluating the resultant tumors by histology and gene expression microarray. Existing sets of gene expression data for human HCC and CC were examined for pathways related to those observed in the murine tumors, and a cohort of human CC samples was evaluated for relationships between HIF-1α expression and clinical outcomes. RESULTS: Both Pten deletion genotypes developed liver tumors, but with differing phenotypes. Pten deletion alone led to large hepatic tumors with widespread hepatosteatosis. Co-deletion of Pten and Vhl with the Keratin 18 promoter resulted in reduced steatosis and a reduced tumor burden that was characterized by a trabecular architecture similar to CC. Genes associated with hepatic steatosis were coordinately expressed in the human HCC dataset, while genes involved in hypoxia response were upregulated in tumors from the human CC dataset. HIF-1α expression and overall survival were examined in an independent cohort of human CC tumors with no statistical differences uncovered. CONCLUSION: Pten deletion in Keratin 18 expressing cells leads to aggressive tumor formation and widespread steatosis in mouse livers. Co-deletion of Vhl and Pten results in lower tumor burden with gene expression profiling suggesting a switch from a profile of lipid deposition to an expression profile more consistent with upregulation of the hypoxia response pathway. A relationship between tumor hypoxia signaling and altered hepatic steatotic response suggests that competing influences may alter tumor phenotypes. 2015-02-01 /pmc/articles/PMC4383253/ /pubmed/25844041 http://dx.doi.org/10.2147/GICTT.S72274 Text en © 2015 Sendor et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) http://dx.doi.org/10.2147/GICTT.S72274 License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php
spellingShingle Article
Sendor, Adam B
Hacker, Kathryn E
Chen, Shufen
Corona, Armando L
Sen, Oishee
Chiang, Derek Y
Snavely, Anna
Rogers, Arlin B
Montgomery, Stephanie A
Rathmell, W Kimryn
McRee, Autumn J
Von Hippel-Lindau status influences phenotype of liver cancers arising from PTEN loss
title Von Hippel-Lindau status influences phenotype of liver cancers arising from PTEN loss
title_full Von Hippel-Lindau status influences phenotype of liver cancers arising from PTEN loss
title_fullStr Von Hippel-Lindau status influences phenotype of liver cancers arising from PTEN loss
title_full_unstemmed Von Hippel-Lindau status influences phenotype of liver cancers arising from PTEN loss
title_short Von Hippel-Lindau status influences phenotype of liver cancers arising from PTEN loss
title_sort von hippel-lindau status influences phenotype of liver cancers arising from pten loss
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4383253/
https://www.ncbi.nlm.nih.gov/pubmed/25844041
http://dx.doi.org/10.2147/GICTT.S72274
work_keys_str_mv AT sendoradamb vonhippellindaustatusinfluencesphenotypeoflivercancersarisingfromptenloss
AT hackerkathryne vonhippellindaustatusinfluencesphenotypeoflivercancersarisingfromptenloss
AT chenshufen vonhippellindaustatusinfluencesphenotypeoflivercancersarisingfromptenloss
AT coronaarmandol vonhippellindaustatusinfluencesphenotypeoflivercancersarisingfromptenloss
AT senoishee vonhippellindaustatusinfluencesphenotypeoflivercancersarisingfromptenloss
AT chiangdereky vonhippellindaustatusinfluencesphenotypeoflivercancersarisingfromptenloss
AT snavelyanna vonhippellindaustatusinfluencesphenotypeoflivercancersarisingfromptenloss
AT rogersarlinb vonhippellindaustatusinfluencesphenotypeoflivercancersarisingfromptenloss
AT montgomerystephaniea vonhippellindaustatusinfluencesphenotypeoflivercancersarisingfromptenloss
AT rathmellwkimryn vonhippellindaustatusinfluencesphenotypeoflivercancersarisingfromptenloss
AT mcreeautumnj vonhippellindaustatusinfluencesphenotypeoflivercancersarisingfromptenloss